Muscle Mass and Strength
6
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
One Year of Velocity-based Resistance Training in Older People Living in Nursing Homes
Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment
Effect of the Consumption of Cookies Enriched With Plant Proteins and of a Vitamin D Supplement on the Progression of Sarcopenia in the Elderly
Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy
Protein Supplementation During Dialysis (PROSED)
A Study to Evaluate the Efficacy of EB-PA on Muscle Mass and Strength in Occasional Gym Goers